Post by KQ Labs

KQ Labs Cohort 8 Demo Day 2026 is in full swing here at the Wellcome Trust! It's been an incredible afternoon of innovation, with inspiring pitches from Respiro Diagnostics, Dimension Biotechnologies, Mechanome Bio, Houdini Bio, and Gramics Bio Ltd. Each team has showcased the impressive progress they have made on the programme with their bold ideas and exciting approaches to tackling some of healthcare's biggest challenges, from diagnostics and therapeutics to cutting-edge biotech and AI-driven solutions. The energy in the room has been fantastic, with founders sharing not only their technologies but also their vision for how these innovations could improve patient outcomes and transform the future of healthcare. And we're only halfway through! Still to come are Fava Health, Eye2Gene, Errigal Bio, Neurolase, and Axiom Therapeutics, all ready to take the stage and share the next wave of breakthrough health technology. It's inspiring to see the culmination of months of hard work, mentorship, collaboration, and ambition from this exceptional cohort. A huge congratulations to all the teams who have presented so far—we're looking forward to an equally exciting second half of the afternoon and to celebrating the achievements of Cohort 8. 👏 – Delivered by the The Francis Crick Institute, KQ Labs is proud to partner with Medicines Discovery Catapult to deliver our eighth cohort, with funding for two oncology-focussed companies from Cancer Research Horizons.